Theravance Biopharma Inc (TBPH)
Investing Cash Flow
-$107.47M
TTM · Period ending: · USD
TBPH Investing Cash Flow
Latest reported-$107.47Mperiod ending
Latest reported-$107.47Mperiod ending
TBPH TTM Cash from Investing (-$2.63M → -$107.47M)
TTM investing cash flow
High-resolution chart · PNG
TBPH investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -107,468,000 | |
| -83,323,000 | |
| -105,284,000 | |
| -90,186,000 | |
| -7,339,000 | |
| 25,888,000 | |
| 12,284,000 | |
| -4,079,000 | |
| 13,299,000 | |
| 27,377,000 | |
| -32,697,000 | |
| 7,141,000 | |
| 1,082,571,000 | |
| 1,079,039,000 | |
| 1,154,009,000 | |
| 1,125,672,000 | |
| 14,470,000 | |
| 42,721,000 | |
| 124,494,000 | |
| 166,073,000 | |
| 268,405,000 | |
| 56,049,000 | |
| 10,755,000 | |
| -27,587,000 | |
| -117,782,000 | |
| 57,512,000 | |
| -83,051,000 | |
| 2,281,000 | |
| 72,584,000 | |
| 115,842,000 | |
| 176,708,000 | |
| 118,565,000 | |
| 86,681,000 | |
| 55,895,000 | |
| -56,333,000 | |
| -143,788,000 | |
| -208,391,000 | |
| -288,142,000 | |
| -148,235,000 | |
| -136,533,000 | |
| -24,604,000 | |
| 85,270,000 | |
| 111,039,000 | |
| 155,226,000 | |
| -16,719,000 | |
| -62,477,000 | |
| -106,251,000 | |
| -117,001,000 | |
| -7,382,000 | |
| -3,614,000 | |
| -2,634,000 | |
| -1,829,000 | |
| -2,059,000 |